MATA NATHAN L.
SEC CIK 2013987 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BLTE | BELITE BIO, INC | CSO | 0 | — | $2.67M | 17 | 2026-04-15 | 2026-05-07 |
Most active insiders at BLTE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lin Yu-Hsin | CEO, Dir | — | $20.82M |
| 2 | Chuang Hao-Yuan | CFO, Dir | — | $14.00M |
| 3 | Scholl Hendrik Peter | Chief Medical Off | — | $2.86M |
| 4 | MATA NATHAN L. | CSO | — | $2.67M |
| 5 | Chen Wan-Shan | Dir | — | $198.5K |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-05-08 16:45 | 2026-05-07 | BLTE | BELITE BIO, INC | MATA NATHAN L. | CSO | S - Sale | $153.21 | -666 | 0 | -100% | -$102.0K |
| MT | 2026-05-07 16:15 | 2026-05-06 | BLTE | BELITE BIO, INC | MATA NATHAN L. | CSO | S - Sale | $153.84 | -1,000 | 666 | -60% | -$153.8K |
| MT | 2026-05-06 16:15 | 2026-05-05 | BLTE | BELITE BIO, INC | MATA NATHAN L. | CSO | S - Sale | $155.50 | -1,000 | 1,666 | -38% | -$155.5K |
| MT | 2026-05-05 16:15 | 2026-05-04 | BLTE | BELITE BIO, INC | MATA NATHAN L. | CSO | S - Sale | $155.64 | -1,000 | 2,666 | -27% | -$155.6K |
| MT | 2026-05-04 16:15 | 2026-05-01 | BLTE | BELITE BIO, INC | MATA NATHAN L. | CSO | S - Sale | $155.78 | -1,000 | 3,666 | -21% | -$155.8K |
| MT | 2026-05-01 16:15 | 2026-04-30 | BLTE | BELITE BIO, INC | MATA NATHAN L. | CSO | S - Sale | $156.97 | -1,000 | 4,666 | -18% | -$157.0K |
| MT | 2026-04-30 16:15 | 2026-04-29 | BLTE | BELITE BIO, INC | MATA NATHAN L. | CSO | S - Sale | $155.82 | -1,000 | 5,666 | -15% | -$155.8K |
| MT | 2026-04-29 16:32 | 2026-04-28 | BLTE | BELITE BIO, INC | MATA NATHAN L. | CSO | S - Sale | $159.16 | -1,000 | 6,666 | -13% | -$159.2K |
| MT | 2026-04-28 16:28 | 2026-04-27 | BLTE | BELITE BIO, INC | MATA NATHAN L. | CSO | S - Sale | $162.64 | -1,000 | 7,666 | -12% | -$162.6K |
| MT | 2026-04-27 16:52 | 2026-04-24 | BLTE | BELITE BIO, INC | MATA NATHAN L. | CSO | S - Sale | $159.56 | -1,000 | 8,666 | -10% | -$159.6K |
| MT | 2026-04-24 16:15 | 2026-04-23 | BLTE | BELITE BIO, INC | MATA NATHAN L. | CSO | S - Sale | $166.28 | -1,000 | 9,666 | -9% | -$166.3K |
| MT | 2026-04-23 16:19 | 2026-04-22 | BLTE | BELITE BIO, INC | MATA NATHAN L. | CSO | S - Sale | $170.38 | -1,000 | 10.7K | -9% | -$170.4K |
| MT | 2026-04-22 16:15 | 2026-04-21 | BLTE | BELITE BIO, INC | MATA NATHAN L. | CSO | S - Sale | $166.00 | -1,000 | 11.7K | -8% | -$166.0K |
| MT | 2026-04-21 17:28 | 2026-04-20 | BLTE | BELITE BIO, INC | MATA NATHAN L. | CSO | S - Sale | $163.59 | -1,000 | 12.7K | -7% | -$163.6K |
| MT | 2026-04-20 16:15 | 2026-04-17 | BLTE | BELITE BIO, INC | MATA NATHAN L. | CSO | S - Sale | $161.63 | -1,000 | 13.7K | -7% | -$161.6K |
| MT | 2026-04-20 16:15 | 2026-04-16 | BLTE | BELITE BIO, INC | MATA NATHAN L. | CSO | S - Sale | $160.38 | -1,000 | 14.7K | -6% | -$160.4K |
| MT | 2026-04-16 16:15 | 2026-04-15 | BLTE | BELITE BIO, INC | MATA NATHAN L. | CSO | S - Sale | $168.30 | -1,000 | 15.7K | -6% | -$168.3K |
Purchase Sale Sale after option exercise All abbreviations